Kavita Nair, PhD, discusses integrating neurology and pharmacy services to improve MS care coordination and reduce treatment delays. The integration of neurology and pharmacy services represents a ...
GRAND RAPIDS, Mich. (WOOD) — A neurologist from Corewell Health joined News 8 to discuss research about multiple sclerosis on World MS Day. “(MS is) an immune-mediated disease, meaning it’s caused by ...
Decreases in daytime activity among adults with MS, indicated via accelerometers worn on their wrists, indicated later development of worse disability and brain atrophy, according to data published in ...
"I think primarily this is a story of discovery," said neurologist and multiple sclerosis (MS) researcher Stephen Hauser, MD, of the University of California San Francisco, about his book, The Face ...
The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this week in JAMA Neurology by a team of international researchers, including a ...
-- for advancing our understanding of immune mechanisms underlying multiple sclerosis and translating them to develop innovative strategies to treat the disease Roland Martin, MD, a world-class ...
—Clinicians may be underestimating the cognitive burden on patients with MS, underscoring the need for more comprehensive cognitive assessments and assessing patient-reported outcomes. A growing body ...
In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...
Among adults with relapsing MS who received ublituximab, the annualized relapse rate continued to drop with up to 5 years of treatment, according to an interim open-label extension study analysis ...
Doctor reading medical chart Investigators hypothesize siponimod will function as an alternative therapeutic choice to monoclonal antibodies in MS. SEATTLE — Prelaunch, neurologists believed that ...
Maternal diabetes and being born large for gestational age are linked to a significantly higher risk for adult-onset multiple sclerosis in offspring.
During a recent five-year period, Medicare spending on hundreds of medicines to treat various neurologic conditions, such as epilepsy and multiple sclerosis, rose 50%, but the number of claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results